Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Payables (2024 - 2025)

RenovoRx (RNXT) has disclosed Payables for 2 consecutive years, with $799000.0 as the latest value for Q4 2025.

  • Quarterly Payables rose 36.35% to $799000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $799000.0 through Dec 2025, up 36.35% year-over-year, with the annual reading at $799000.0 for FY2025, 36.35% up from the prior year.
  • Payables hit $799000.0 in Q4 2025 for RenovoRx, down from $869000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $967000.0 in Q1 2025 to a low of $356000.0 in Q1 2024.